Issue: October 2021

Read more

October 20, 2021
1 min read
Save

ENVISAGE-TAVI AF

Issue: October 2021
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Edoxaban (Savaysa, Daiichi Sankyo) or vitamin K antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement.